The Role of 750 mg Once-Daily Levofloxacin in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Diseases

29 March, 2018

Question 16

What were the benefits associated with using this levofloxacin treatment schedule in ABECB patients?

The major benefits of using levofloxacin in ABECB were the following:
・shorter duration of therapy
・potential of improved compliance
・decreased overall antimicrobial exposure
・excellent cure rates
・faster resolution of symptoms compared to amoxicillin/clavulanate